Ligence Heart vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Ligence
VS
by Verily

AI Verdict

Ligence Heart is an AI platform designed to automate the analysis and reporting of 2D transthoracic echocardiography images, directly assisting cardiologists with diagnostic efficiency. In contrast, Verily Study Watch is a wearable device focused on continuous, non-invasive physiological data collection, primarily for clinical research and remote monitoring. While both utilize AI in cardiology, Ligence Heart targets diagnostic image interpretation, whereas Study Watch focuses on real-time physiological data acquisition.

Choose Ligence Heart if…

Choose Ligence Heart if your cardiology department aims to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis. This AI-powered platform is ideal for automating complex measurements, generating comprehensive reports, and aiding in disease recognition, thereby streamlining the diagnostic workflow for cardiologists and sonographers.

View Ligence Heart →

Choose Study Watch if…

Choose Verily Study Watch if your clinical research requires continuous, long-term physiological data collection from study participants. This prescription-only wearable device is specifically designed for research settings, enabling the capture of multi-modal data like ECG and heart rate over extended periods for in-depth analysis in a secure cloud platform.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Ligence Heart Study Watch
Pricing Contact-for-pricing Unknown
Deployment Cloud-based; on-premise; hybrid The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart is a web-based platform designed to automate complex echocardiography analysis and reporting, directly enhancing diagnostic efficiency for cardiologists and sonographers. Its integration with existing PACS, EHR, and RIS systems also streamlines clinical workflows, making it highly usable within a professional setting.

Clinical Value

Ligence Heart

Both tools are FDA cleared, indicating clinical utility. However, Ligence Heart directly enhances diagnostic accuracy and efficiency by automating the analysis and reporting of 2D transthoracic echocardiography, including disease recognition for specific cardiac conditions. While Study Watch offers valuable continuous physiological monitoring for research, Ligence Heart provides more immediate and tangible clinical value for routine patient diagnosis and management.

Pricing & Value

Tie

Neither Ligence Heart nor Verily Study Watch provides publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. Both operate on an enterprise quote or partnership model. Without transparent pricing, it is difficult to definitively assess which offers better value for money.

Enterprise Readiness

Ligence Heart

Ligence Heart offers flexible deployment options including cloud, on-premise, and hybrid, alongside explicit integration capabilities with PACS, EHR, and RIS, which are critical for seamless enterprise adoption. While Verily Study Watch is cloud-based and claims HIPAA compliance, ongoing lawsuit allegations regarding BAA breaches, even if denied, introduce a potential concern for enterprise legal and compliance teams.

Innovation

Ligence Heart

Ligence Heart demonstrates significant innovation by leveraging AI to automate the highly skilled and time-consuming process of echocardiography analysis, including automated measurements and disease recognition. This directly addresses a critical bottleneck in clinical diagnostics. While Study Watch's multi-sensor continuous monitoring is innovative for data collection in research, Ligence Heart's direct application of AI to streamline and enhance a core diagnostic procedure stands out.

Support & Docs

Study Watch

Verily Study Watch offers more structured support resources, including Data Workbench resources with forums, tutorials, and product documentation, as well as a user manual. Ligence Heart primarily provides an Instructions for Use (IFU) document and directs users to contact them via email for technical support, with mentions of training videos.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Ligence Heart Study Watch
Primary Function AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Company Ligence Verily Life Sciences
Key Feature Type Automated recognition, classification, measurement, and report generation for echocardiography imaging data; disease recognition. Continuous physiological monitoring via multiple sensors (ECG, heart rate, electrodermal activity, inertial movements); cloud-based data processing; on-demand single-channel ECG; irregular pulse monitor.
Target Specialties Cardiology Cardiology, Neurology, Sleep Medicine

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers. Verily Study Watch is a prescription-only, sensor-based wearable device primarily used for non-invasive, continuous physiological monitoring in clinical research.
Ligence Heart transfers echocardiography images (with PHI removed) from hospital PACS for automated analysis and report generation. Verily Study Watch collects continuous physiological data like ECG, heart rate, and movement directly from the wearable device, which is then uploaded to Verily's cloud platform for processing.
Ligence Heart provides automated calculations of measurements, report generation, and disease recognition for conditions like heart failure and valvular heart diseases, including automated strain and Doppler measurements. Verily Study Watch offers continuous physiological monitoring, on-demand single-channel ECG, and an irregular pulse monitor, with data processed by algorithms and machine learning in the cloud.
Both Ligence Heart and Verily Study Watch are FDA cleared, HIPAA compliant, and have a BAA. However, while Verily states adherence to HIPAA and conducts independent audits, an ongoing lawsuit alleges breaches of BAAs and HIPAA violations, which Verily denies.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.